SecurityScorecard Enables Organizations to View Risks and Measure the ROI of Security Investments in the Midst of Turbulent Economic Times

New content and ROI calculator helps security leaders quantify and communicate the value of security…

Indonesia Agritech Market Report 2022: Market Revenue Grew at a CAGR of ~39.7 % During FY’16-FY’21 – Outlook to 2026 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Indonesia Agritech Market Outlook to 2026" report has been added to ResearchAndMarkets.com's offering.…

NTT Research Names Takashi Goto Head of the Technology Promotion Team

Former director at NTT R&D to explore market potential of research, including attribute-based encryption SUNNYVALE,…

Large, Multi-Center, Multi-Society Study of Impella-supported Patients Finds 30-day AMI Cardiogenic Shock Survival of 81%

BOSTON--(BUSINESS WIRE)--Results of a three-year, investigator-led study of all Impella-supported patients treated at 109 hospitals…

Takeda Signs Virtual Power Purchase Agreement with Enel North America to Advance Renewable Energy Production in the United States

- 12-Year Agreement Prioritizes Environmental Stewardship to Help Create Clean Energy Solutions and Advances Progress…

PPG’s New Paint for a New Start transforms 36 schools worldwide with colorful makeovers

Initiative is part of company’s ongoing COLORFUL COMMUNITIES program PITTSBURGH--(BUSINESS WIRE)--PPG (NYSE: PPG) today announced…

BigCommerce Finds Brands Must Keep Pace with Factors Driving Consumer Behavior in New Global Consumer Report

Current and Future Shopping Trends survey provides retailers with insight into key factors shaping how…

Indonesia Used Smartphone Market Outlook to 2026: Market to Grow at a CAGR of 9% – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Indonesia Used Smartphone Market Outlook to 2026" report has been added to ResearchAndMarkets.com's…

BeiGene Receives Positive CHMP Opinion for BRUKINSA® (zanubrutinib) for the Treatment of Adults with Marginal Zone Lymphoma

CHMP recommends approval of BRUKINSA for the treatment of relapsed or refractory marginal zone lymphoma…